within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B05A_BloodAndRelatedProducts.B05AX04_StemCellsFromUmbilicalCordBlood;

model StemCellsFromUmbilicalCordBlood
  extends Pharmacolibrary.Drugs.ATC.B.B05AX04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>B05AX04</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Stem cells from umbilical cord blood are hematopoietic progenitor cells harvested from the blood of the umbilical cord at birth. They are used primarily for hematopoietic stem cell transplantation and regenerative medicine, often to treat disorders such as leukemia, lymphoma, and some genetic blood diseases. This is an approved therapy in many countries for these indications.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic parameters are available for stem cells from umbilical cord blood, as stem cell therapies involve living cells with complex biodistribution, engraftment, and persistence properties rather than conventional ADME pharmacokinetics typical of small molecule drugs. Literature does not report standard PK parameters for cell-based therapies in intravenous infusion in pediatric or adult subjects.</p><h4>References</h4><ol><li><p>Liu, G, et al., &amp; Liu, Y (2024). Neuroprotection of Human Umbilical Cord-Derived Mesenchymal Stem Cells (hUC-MSCs) in Alleviating Ischemic Stroke-Induced Brain Injury by Regulating Inflammation and Oxidative Stress. <i>Neurochemical research</i> 49(10) 2871–2887. DOI:<a href=\"https://doi.org/10.1007/s11064-024-04212-x\">10.1007/s11064-024-04212-x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39026086/\">https://pubmed.ncbi.nlm.nih.gov/39026086</a></p></li><li><p>Ehrhart, J, et al., &amp; Tan, J (2016). Biodistribution of Infused Human Umbilical Cord Blood Cells in Alzheimer&#x27;s Disease-Like Murine Model. <i>Cell transplantation</i> 25(1) 195–199. DOI:<a href=\"https://doi.org/10.3727/096368915X689604\">10.3727/096368915X689604</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26414627/\">https://pubmed.ncbi.nlm.nih.gov/26414627</a></p></li><li><p>Mukherjee, A, et al., &amp; Venkatesh, M (2012). Radiolabeling of umbilical cord-derived mesenchymal stem cells for in vivo tracking. <i>Cancer biotherapy &amp; radiopharmaceuticals</i> 27(9) 614–619. DOI:<a href=\"https://doi.org/10.1089/cbr.2011.1146\">10.1089/cbr.2011.1146</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23046460/\">https://pubmed.ncbi.nlm.nih.gov/23046460</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end StemCellsFromUmbilicalCordBlood;
